Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial
by Karakas, Mahir (Author)
, Akın, Ibrahim (Author)
, Burdelski, Christoph (Author)
, Clemmensen, Peter (Author)
, Grahn, Hanno (Author)
, Jarczak, Dominik (Author)
, Keßler, Mirjam (Author)
, Kirchhof, Paulus (Author)
, Landmesser, Ulf (Author)
, Lezius, Susanne (Author)
, Lindner, Diana (Author)
, Mebazaa, Alexandre (Author)
, Nierhaus, Axel (Author)
, Ocak, Anil (Author)
, Rottbauer, Wolfgang (Author)
, Sinning, Christoph (Author)
, Skurk, Carsten (Author)
, Söffker, Gerold (Author)
, Westermann, Dirk (Author)
, Zapf, Antonia (Author)
, Zengin, Elvin (Author)
, Zeller, Tanja (Author)
, Kluge, Stefan (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource